Li Kang Valuation
| 6242 Stock | TWD 44.60 0.20 0.45% |
At this time, the firm appears to be overvalued. Li Kang Biomedical owns a latest Real Value of NT$41.5 per share. The recent price of the firm is NT$44.6. Our model forecasts the value of Li Kang Biomedical from inspecting the firm fundamentals such as Return On Asset of 0.12, shares owned by insiders of 72.30 %, and Profit Margin of 0.16 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Li Kang's price fluctuation is very steady at this time. Calculation of the real value of Li Kang Biomedical is based on 3 months time horizon. Increasing Li Kang's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the 6242 stock is determined by what a typical buyer is willing to pay for full or partial control of Li Kang Biomedical. Since Li Kang is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 6242 Stock. However, Li Kang's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 44.6 | Real 41.5 | Hype 44.6 | Naive 44.6 |
The intrinsic value of Li Kang's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Li Kang's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Li Kang Biomedical helps investors to forecast how 6242 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Li Kang more accurately as focusing exclusively on Li Kang's fundamentals will not take into account other important factors: Li Kang Total Value Analysis
Li Kang Biomedical is presently anticipated to have takeover price of 1.05 B with market capitalization of 1.37 B, debt of 24.59 M, and cash on hands of 187.44 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Li Kang fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.05 B | 1.37 B | 24.59 M | 187.44 M |
Li Kang Investor Information
About 72.0% of the company shares are owned by insiders or employees . The book value of Li Kang was presently reported as 23.12. The company last dividend was issued on the 4th of July 2022. Li Kang Biomedical had 1000:1150 split on the 30th of June 2023. Li Kang Biomedical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Li Kang Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Li Kang has an asset utilization ratio of 62.81 percent. This indicates that the Company is making NT$0.63 for each dollar of assets. An increasing asset utilization means that Li Kang Biomedical is more efficient with each dollar of assets it utilizes for everyday operations.Li Kang Ownership Allocation
Li Kang Biomedical secures a total of 23.31 Million outstanding shares. Li Kang Biomedical owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 72.3 % of Li Kang Biomedical outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.Li Kang Profitability Analysis
The company reported the revenue of 386.97 M. Net Income was 51.44 M with profit before overhead, payroll, taxes, and interest of 264.68 M.About Li Kang Valuation
Our relative valuation model uses a comparative analysis of Li Kang. We calculate exposure to Li Kang's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Li Kang's related companies.Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drinks. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan. LI KANG operates under Travel Services classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 123 people.
8 Steps to conduct Li Kang's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Li Kang's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Li Kang's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Li Kang's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Li Kang's revenue streams: Identify Li Kang's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Li Kang's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Li Kang's growth potential: Evaluate Li Kang's management, business model, and growth potential.
- Determine Li Kang's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Li Kang's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for 6242 Stock Analysis
When running Li Kang's price analysis, check to measure Li Kang's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Li Kang is operating at the current time. Most of Li Kang's value examination focuses on studying past and present price action to predict the probability of Li Kang's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Li Kang's price. Additionally, you may evaluate how the addition of Li Kang to your portfolios can decrease your overall portfolio volatility.